Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share Capital (Tables)

v3.20.2
Share Capital (Tables)
6 Months Ended
Jun. 30, 2020
Share Capital [Abstract]  
Summary of shares sold under share purchase agreement
Between January 3, 2020 and February 13, 2020, the Company issued 4,408,048 common shares pursuant to the Second Aspire Agreement as outlined in the following table:

Grant Date
 
Common shares issued
   
Value
 
January 3, 2020
   
500,000
   
$
219,600
 
January 6, 2020
   
500,000
     
229,300
 
January 8, 2020
   
400,000
     
195,160
 
January 10, 2020
   
500,000
     
247,550
 
January 17, 2020
   
600,000
     
303,000
 
January 23, 2020
   
600,000
     
295,320
 
February 6, 2020
   
600,000
     
282,000
 
February 13, 2020
   
708,048
     
300,000
 
     
4,408,048
   
$
2,071,930
 
Subsequent to August 29, 2019 and subject to the First Aspire Agreement, the Company issued Common Shares to Aspire as outlined in the following table:
Grant Date
 
Common shares issued
   
Value
 
August 30, 2019
   
2,417,162
   
$
3,000,000
 
November 8, 2019
   
100,000
     
42,560
 
November 8, 2019
   
100,000
     
42,560
 
November 12, 2019
   
100,000
     
42,970
 
November 12, 2019
   
100,000
     
42,000
 
November 13, 2019
   
100,000
     
42,970
 
November 14, 2019
   
300,000
     
128,910
 
November 15, 2019
   
2,500,000
     
1,074,250
 
November 19, 2019
   
2,067,282
     
888,311
 
 
   
7,784,444
   
$
5,304,531
 
Summary of Options Outstanding
A summary of the status of the Company’s outstanding stock options as of June 30, 2020 and December 31, 2019 and changes during the periods ended on those dates is presented in the following table:

    
Six Months Ended June 30, 2020
   
Year Ended December 31, 2019
 
Stock Options - CDN $ denominated
 
Number of
Stock
Options
 
Weighted average Exercise Price (CDN)
   
Number of
Stock
Options
 
Weighted average Exercise Price
(CDN)
 
                         
Balance beginning
   
860,379
   
$
5.89
     
875,433
   
$
18.20
 
Granted
   
25,765
     
0.66
     
35,719
     
4.54
 
Expired / forfeited
   
(17,980
)
   
24.55
     
(50,773
)
   
31.79
 
Balance ending
   
868,164
   
$
5.46
     
860,379
   
$
5.89
 
                                 
Stock Options - USD $ denominated
 
Number of Stock Options
 
Weighted average Exercise Price (USD)
   
Number of Stock Options
 
Weighted average Exercise Price (USD)
 
                                 
Balance beginning
   
854,042
   
$
2.65
     
50,349
   
$
1.55
 
Granted
   
-
     
-
     
843,693
     
2.72
 
Expired / forfeited
   
(467,255
)
   
2.20
     
(40,000
)
   
3.72
 
Balance ending
   
386,787
   
$
3.19
     
854,042
   
$
2.65
 
                                 
Total number of stock options
   
1,254,951
             
1,714,421
         
Summary of Weighted-Average Remaining Contractual Life and Weighted-Average Exercise Price Options Outstanding and Options Exercisable on Exercise Prices
The weighted-average remaining contractual life and weighted-average exercise price of options outstanding and of options exercisable as at June 30, 2020 are as follows:

Canadian Dollar Denominated Options
 
Exercise Price (CDN)
 
Number Outstanding
 
Weighted-
average remaining contractual life (years)
 
Options Exercisable
 
 
$
0.66
     
25,765
     
6.58
     
25,765
 
 
$
3.28
     
31,498
     
5.17
     
31,498
 
 
$
4.50
     
18,936
     
2.78
     
18,936
 
 
$
4.54
     
735,998
     
3.77
     
379,030
 
 
$
4.80
     
3,040
     
0.21
     
3,040
 
 
$
9.00
     
11,481
     
5.02
     
11,481
 
 
$
9.60
     
1,105
     
0.27
     
1,105
 
 
$
11.70
     
6,667
     
0.44
     
6,667
 
 
$
12.00
     
1,948
     
0.43
     
1,948
 
 
$
30.00
     
28,260
     
1.15
     
28,260
 
 
$
30.60
     
2,096
     
0.48
     
2,096
 
 
$
32.40
     
810
     
0.58
     
810
 
 
$
45.30
     
560
     
0.12
     
560
 
           
868,164
     
3.75
     
511,196
 
                               
US Dollar Denominated Options
 
Exercise Price (USD)
 
Number Outstanding
 
Weighted-average remaining contractual life (years)
 
Options Exercisable
 
 
$
1.55
     
50,349
     
1.47
     
50,349
 
 
$
2.20
     
2,165
     
2.05
     
2,165
 
 
$
3.40
     
294,273
     
5.87
     
197,273
 
 
$
3.72
     
40,000
     
2.19
     
-
 
           
386,787
     
5.14
     
249,787
 
                               
Total
     
1,254,951
     
4.11
     
760,983
 
Summary of Inputs Used in Measurement of Fair Values at Grant Date of Share Based Option Plan
The weighted average inputs in the original currency of the grants (CDN$ or US$) used in the measurement of fair values at grant date of the share-based option grants for the six months ended June 30, 2020 and 2019 are as follows:
   
2020 - CDN
   
2019 – US
 
Fair value calculated
 
CDN $0.43
   
US $1.76
 
Share price at grant
 
CDN $0.62
   
US $2.84
 
Exercise price
 
CDN $0.66
   
US $3.40
 
Expected option life
 
3.5 years
   
3.5 years
 
Risk free interest rate (based on government bonds)
   
1.41
%
   
1.61
%
Expected volatility
   
109.00
%
   
98.43
%
Expected dividends
 
Nil
   
Nil